Pemetrexed (brand name Alimta) is a chemotherapy drug. Its indications are the treatment of pleural mesothelioma as well as non-small cell lung cancer.
The molecular structure of pemetrexed was developed by Edward C. Taylor at Princeton University and clinically developed by Indianapolis based drug maker, Eli Lilly and Company.
More on [ Pemetrexed ]

Alimta.com - Lilly - Official pharmaceutical site with information for patients and health professionals.
Meta Description: [ Eli Lilly provides information on ALIMTA, approved as a single-agent for the treatment of non-small cell lung cancer and in combination with cisplatin by the FDA for the treatment of malignant pleural mesothelioma. Includes therapy options, FAQ's, safety information, and links to cancer resources. ]
| Pemetrexed | |